๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Autoimmune Hemolytic Anemia

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site๐Ÿ“ Sioux Falls Sanford Health CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed โ‰ฅ3 Lines of Therapy. NCT06733610Phase 11 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: universal allogeneic anti-CD19/BCMA CAR T-cells Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia NCT05931718n/a1 site๐Ÿ“ Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico ยท Tests: cytokine essays, NGS, Fecal microbiome, Erythropoietin, Luspatercept Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders NCT07104565Phase 239 sites๐Ÿ“ Glendale๐Ÿ“ Los Angeles๐Ÿ“ Lone Tree Incyte Corporation ยท Tests: INCA000585 Safety Study of CC312 in Autoimmune Disease Patients NCT06888960EARLY Phase 11 site๐Ÿ“ Tianjin CytoCares Inc ยท Tests: CC312 Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT NCT01962415Phase 21 site๐Ÿ“ Pittsburgh Paul Szabolcs ยท Tests: Hydroxyurea, Alemtuzumab, Fludarabine, Melphalan, Thiotepa Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study NCT05089227Phase 21 site๐Ÿ“ Dijon Centre Hospitalier Universitaire Dijon ยท Tests: treatment "intervention", treatment "standard", biological assessment Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of Arnovie101, an mRNA-LNP-Based In Vivo CAR-T Therapy, for the Treatment of B Cell-Mediated Autoimmune Diseases (SLE and AIHA) NCT07629596EARLY Phase 11 site๐Ÿ“ Beijing Circunited BioPharma (Shenzhen) Co., Ltd. ยท Tests: Arnovie101 Infusion Intravenous Brain Cognitive Network Abnormalities in Anemia Patients Using fNIRS NCT07578675n/a1 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease NCT07549698Phase 1, Phase 212 sites๐Ÿ“ Boston๐Ÿ“ Rochester๐Ÿ“ Omaha CRISPR Therapeutics AG ยท Tests: CTX112 Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia NCT04005638n/a1 site๐Ÿ“ Pessac University Hospital, Bordeaux ยท Tests: blood sample, urine sample UCAR T-cell Therapy Targeting CD19/BCMA in Relapsed/Refractory Autoimmune Hemolytic Anemia NCT07530380EARLY Phase 11 site๐Ÿ“ Hefei The Second Hospital of Anhui Medical University ยท Tests: QT-219C Cell Injection Study of Ultomirisยฎ (Ravulizumab) Safety in Pregnancy NCT06312644n/a7 sites๐Ÿ“ Boston๐Ÿ“ Melbourne๐Ÿ“ Paris Alexion Pharmaceuticals, Inc. ยท Tests: Ultomiris OM336 in Autoimmune Cytopenias NCT07083960Phase 17 sites๐Ÿ“ Duarte๐Ÿ“ Washington D.C.๐Ÿ“ Ann Arbor Lakefront Biotherapeutics West LLC ยท Tests: OM336 Orelabrutinib in the Treatment of Relapsed/Refractory AIHA NCT07453368Phase 21 site๐Ÿ“ Beijing Peking Union Medical College Hospital ยท Tests: Orelabrutinib-50, Orelabrutinib-100, Orelabrutinib-150 A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia NCT07205315EARLY Phase 12 sites๐Ÿ“ Zhengzhou๐Ÿ“ Tianjin Grit Biotechnology ยท Tests: GT801 Injection Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC NCT04528355n/a1 site๐Ÿ“ Pittsburgh Paul Szabolcs ยท Tests: data collection French Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia NCT02877706n/a1 site๐Ÿ“ Toulouse University Hospital, Toulouse ยท Tests: no specific intervention Brain Function and Psychological Changes Related to Cell Therapy for Autoimmune Hemolytic Anemia NCT06921980n/a1 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Brain function and psychological assessment HY001N for Patients With Autoimmune Hemolytic Anemia After Failure โ‰ฅ3 Lines of Therapy. NCT07748533Phase 11 site๐Ÿ“ Tianjin Juventas Cell Therapy Ltd. ยท Tests: HY001N Cell Injection National Longitudinal Cohort of Hematological Diseases- Autoimmune Hemolytic Anemia NCT07019038n/a1 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: A combined retrospective and prospective observational follow-up Second-line Treatment of Primary Autoimmune Hemolytic Anemia NCT05057468Phase 32 sites๐Ÿ“ Asyut๐Ÿ“ Asyut Assiut University ยท Tests: Cyclosporine, Rituximab IASO-782 in Autoimmune Hematological Diseases NCT06534021Phase 12 sites๐Ÿ“ Wuhan๐Ÿ“ Tianjin Shanghai IASO Biotechnology Co., Ltd ยท Tests: IASO-782 injection, placebo National Longitudinal Cohort of Hematological Diseases NCT04645199n/a1 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China National Registry of Rare Kidney Diseases NCT06065852n/a1 site๐Ÿ“ Bristol UK Kidney Association A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia NCT07086976Phase 3105 sites๐Ÿ“ Phoenix๐Ÿ“ Tucson๐Ÿ“ Duarte Sanofi ยท Tests: rilzabrutinib, placebo Sirolimus in the Treatment of Refractory/Relapsed wAIHA NCT05925023NA1 site๐Ÿ“ Beijing Peking Union Medical College Hospital ยท Tests: Sirolimus Autoimmune Hemolytic Anemia and Its Clinical Implication on Antiphospholipid Syndrome NCT07743242NA1 site๐Ÿ“ Al Khฤrjah New Valley University ยท Tests: Hemoglobin, Coombs test UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases NCT07441525EARLY Phase 11 site๐Ÿ“ Wuhan Union Hospital, Tongji Medical College, Huazhong Universityโ€ฆ ยท Tests: CART Infusion A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia NCT07175493Phase 1, Phase 23 sites๐Ÿ“ Zhengzhou๐Ÿ“ Changzhi๐Ÿ“ Tianjin Keymed Biosciences Co.Ltd ยท Tests: CM336 Injection
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy